Alternative (acidic) bile acid biosynthesis pathway (Homo sapiens)

From WikiPathways

Revision as of 17:01, 18 December 2025 by Jmrodriguezc (Talk | contribs)
Jump to: navigation, search


Description

This pathway depicts the alternative (acidic) route of primary bile acid synthesis, in which cholesterol is first hydroxylated on the side chain at C24, C25 or C26 by enzymes such as CYP46A1, CH25H or CYP27A1 to generate regulatory oxysterols including cerebrosterol, 24 , 25 and 27 hydroxycholesterol and their 7α hydroxylated derivatives (for example 7α,24 , 7α,25 and 7α,27 dihydroxycholesterol). These are then further oxidized to 7α,24/25/26-dihydroxy-4-cholesten-3-one (ST 27:2;(24/25/26)O3). From this common intermediate, 12α hydroxylation by CYP8B1 can drive formation of cholic acid (CA), whereas bypassing CYP8B1 favours chenodeoxycholic acid (CDCA), with downstream ring reduction and side chain shortening steps (involving HSD3B7, AKR1D1, AKR1C4, CYP27A1 and peroxisomal β oxidation enzymes) converging with the classical pathway from one side at 3α,7α-dihydroxy-5β-cholestan-26-al (ST 27:1;O3) and related intermediates to yield CDCA, and from the other side at 3α,7α,12α-trihydroxy-5β-cholestan-26-al (ST 27:1;O4) and related intermediates to yield CA.

For the metabolite labels, the “ST 27:x;Oy” codes follow the LIPID MAPS sterol sum‑composition notation, in which “ST 27:1;O2” denotes a C27 sterol with one double‑bond equivalent and two oxygens, and the variants used here (for example ST 27:1;(24)O3) extend this format by indicating the position of selected hydroxyl groups, such as a 24‑hydroxy substituent.



>> Metabolite and enzyme abbreviations used with their full common names:

  • Cholesterol: Cholesterol
  • ST 27:1;O2: Cerebrosterol
  • ST 27:1;(24)O3: 7alpha,24-dihydroxycholesterol
  • ST 27:1;(25)O2: 25-hydroxy-cholesterol
  • ST 27:1;(25)O3: 7alpha,25-dihydroxycholesterol
  • ST 27:1;(27)O3: 7alpha,27-dihydroxycholesterol
  • ST 27:1;(27)O2: 27-hydroxy-cholesterol
  • ST 27:2;O3: Cholestenoic acid
  • ST 27:2;O4: 3beta,7alpha-Dihydroxy-5-cholestenoic acid
  • ST 27:3;O4: 7alpha-hydroxy-3-oxocholest-4-en-27-oic acid
  • ST 27:2;(24)O3: 7alpha,24-dihydroxycholest-4-en-3-one
  • ST 27:2;(25)O3: 7alpha,25-dihydroxycholest-4-en-3-one
  • ST 27:2;(26)O3: 7alpha,26-dihydroxycholest-4-en-3-one
  • ST 27:2;(24)O4: 7alpha,12alpha,24-trihydroxycholest-4-en-3-one
  • ST 27:2;(25)O4: 7alpha,12alpha,25-trihydroxycholest-4-en-3-one
  • ST 27:2;(26)O4: 7alpha,12alpha,26-trihydroxycholest-4-en-3-one
  • ST 27:1;(24)O4: 7alpha,12alpha,24-trihydroxy-5beta-cholestan-3-one
  • ST 27:1;(25)O4: 7alpha,12alpha,25-trihydroxy-5beta-cholestan-3-one
  • ST 27:1;(26)O4: 7alpha,12alpha,26-trihydroxy-5beta-cholestan-3-one
  • ST 27:0;(24)O4: 5beta-Cholestane-3alpha,7alpha,12alpha,24-tetrol
  • ST 27:0;(25)O4: 5beta-Cholestane-3alpha,7alpha,12alpha,25-tetrol
  • ST 27:0;(26)O4: 5beta-Cholestane-3alpha,7alpha,12alpha,26-tetrol
  • ST 27:1;O4: 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-26-al
  • CA: Cholic acid
  • ST 27:1;(24)O3: 7alpha,24-dihydroxy-5beta-cholestan-3-one
  • ST 27:1;(25)O3: 7alpha,25-dihydroxy-5beta-cholestan-3-one
  • ST 27:1;(26)O3: 7alpha,26-dihydroxy-5beta-cholestan-3-one
  • ST 27:0;(24)O3: 5beta-cholestane-3alpha,7alpha,24-triol
  • ST 27:0;(25)O3: 5beta-cholestane-3alpha,7alpha,25-triol
  • ST 27:0;(26)O3: 5beta-cholestane-3alpha,7alpha,26-triol
  • ST 27:1;O3: 3alpha,7alpha-dihydroxy-5beta-cholestan-26-al
  • CDCA: Chenodeoxycholic acid
  • CYP39A1: 24-hydroxycholesterol 7-alpha-hydroxylase, cytochrome P450, family 39, subfamily A, polypeptide 1
  • HSD3B7: hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7
  • CYP46A1: cholesterol 24-hydroxylase, cytochrome P450, family 46, subfamily A, polypeptide 1
  • CH25H: cholesterol 25-hydroxylase
  • CYP7B1: 25-hydroxycholesterol 7-alpha-hydroxylase, cytochrome P450, family 7, subfamily B, polypeptide 1
  • CYP27A1: sterol 26-hydroxylase, mitochondrial precursor, cytochrome P450, family 27, subfamily A, polypeptide 1
  • CYP8B1: 7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase, cytochrome P450, family 8, subfamily B, polypeptide 1
  • AKR1D1: 3-oxo-5beta-steroid 4-dehydrogenase, aldo-keto reductase family 1, member D1
  • AKR1C4: 3-alpha hydroxysteroid dehydrogenase, aldo-keto reductase family 1, member C4
  • CYP7A1: cholesterol 7-alpha-monooxygenase, cytochrome P450 7A1
  • Classic/Neutral BA biosynthesis: Pathway → Disorders of bile acid synthesis and biliary transport

Please use the New WikiPathways

View approved pathways at the new wikipathways.org. This website will shutdown soon.

Quality Tags

Ontology Terms

 

Bibliography

View all...
  1. Zhuang T, Wang X, Wang Z, Gu L, Yue D, Li X, Yang L, Huang W, Ding L; ''Biological functions and pharmacological behaviors of bile acids in metabolic diseases.''; J Adv Res, 2025 PubMed Europe PMC Scholia
  2. Griffiths WJ, Wang Y; ''Oxysterols as lipid mediators: Their biosynthetic genes, enzymes and metabolites.''; Prostaglandins Other Lipid Mediat, 2020 PubMed Europe PMC Scholia
  3. Russell DW; ''The enzymes, regulation, and genetics of bile acid synthesis.''; Annu Rev Biochem, 2003 PubMed Europe PMC Scholia
  4. Collins SL, Stine JG, Bisanz JE, Okafor CD, Patterson AD; ''Bile acids and the gut microbiota: metabolic interactions and impacts on disease.''; Nat Rev Microbiol, 2023 PubMed Europe PMC Scholia
  5. Ferdinandusse S, Houten SM; ''Peroxisomes and bile acid biosynthesis.''; Biochim Biophys Acta, 2006 PubMed Europe PMC Scholia
  6. Paul A. Dawson.; ''6. Biochemistry of Lipids, Lipoproteins and Membranes (Sixth Edition), Chapter 12 - Bile Acid Metabolism''; https://doi.org/10.1016/B978-0-444-63438-2.00012-2, 2016
  7. Griffiths WJ, Crick PJ, Meljon A, Theofilopoulos S, Abdel-Khalik J, Yutuc E, Parker JE, Kelly DE, Kelly SL, Arenas E, Wang Y; ''Additional pathways of sterol metabolism: Evidence from analysis of Cyp27a1-/- mouse brain and plasma.''; Biochim Biophys Acta Mol Cell Biol Lipids, 2019 PubMed Europe PMC Scholia
  8. Chiang JY; ''Bile acid metabolism and signaling.''; Compr Physiol, 2013 PubMed Europe PMC Scholia

History

View all...
CompareRevisionActionTimeUserComment
142280view17:20, 24 December 2025JmrodriguezcOntology Term : 'secondary bile acid biosynthetic pathway' added !
142279view17:20, 24 December 2025JmrodriguezcOntology Term : 'primary bile acid biosynthetic pathway' added !
142278view17:20, 24 December 2025JmrodriguezcOntology Term : 'bile acid biosynthetic pathway' added !
142251view12:00, 22 December 2025JmrodriguezcModified description
142250view11:57, 22 December 2025JmrodriguezcModified description
142236view17:46, 18 December 2025JmrodriguezcModified description
142235view17:35, 18 December 2025JmrodriguezcModified description
142234view17:01, 18 December 2025JmrodriguezcModified description
142233view13:50, 18 December 2025JmrodriguezcNew pathway

External references

DataNodes

View all...
NameTypeDatabase referenceComment
AKR1C4GeneProductLMP000718 (LIPID MAPS)
AKR1D1GeneProductLMP001665 (LIPID MAPS)
CAMetaboliteLMST04010001 (LIPID MAPS)
CDCAMetaboliteLMST04010032 (LIPID MAPS)
CH25HGeneProductLMP001605 (LIPID MAPS)
CYP27A1GeneProductLMP002471 (LIPID MAPS)
CYP39A1GeneProductLMP001831 (LIPID MAPS)
CYP46A1GeneProductLMP002143 (LIPID MAPS)
CYP7A1GeneProductLMP000667 (LIPID MAPS)
CYP7B1GeneProductLMP000599 (LIPID MAPS)
CYP8B1GeneProductLMP000541 (LIPID MAPS)
CholesterolMetaboliteLMST01010001 (LIPID MAPS)
Classic/Neutral BA biosynthesis pathwayPathwayWP5176 (WikiPathways)
HSD3B7GeneProductLMP001669 (LIPID MAPS)
ST 27:0;(24)O3MetaboliteLMST04030022 (LIPID MAPS)
ST 27:0;(24)O4MetaboliteLMST04030034 (LIPID MAPS)
ST 27:0;(25)O3MetaboliteLMST04030021 (LIPID MAPS)
ST 27:0;(25)O4MetaboliteLMST04030037 (LIPID MAPS)
ST 27:0;(26)O3MetaboliteLMST04030020 (LIPID MAPS)
ST 27:0;(26)O4MetaboliteLMST04030014 (LIPID MAPS)
ST 27:1;(24)O3MetaboliteLMST04030169 (LIPID MAPS)
ST 27:1;(24)O3MetaboliteLMST04030174 (LIPID MAPS)
ST 27:1;(24)O4MetaboliteLMST04030172 (LIPID MAPS)
ST 27:1;(25)O2MetaboliteLMST01010018 (LIPID MAPS)
ST 27:1;(25)O3MetaboliteLMST04030106 (LIPID MAPS)
ST 27:1;(25)O3MetaboliteLMST04030166 (LIPID MAPS)
ST 27:1;(25)O4MetaboliteLMST04030104 (LIPID MAPS)
ST 27:1;(26)O3MetaboliteLMST04030156 (LIPID MAPS)
ST 27:1;(26)O4MetaboliteLMST04030100 (LIPID MAPS)
ST 27:1;(27)O2MetaboliteLMST01010057 (LIPID MAPS)
ST 27:1;(27)O3MetaboliteLMST04030081 (LIPID MAPS)
ST 27:1;O2MetaboliteLMST01010019 (LIPID MAPS)
ST 27:1;O3MetaboliteLMST04030162 (LIPID MAPS)
ST 27:1;O4MetaboliteLMST04030164 (LIPID MAPS)
ST 27:2;(24)O3MetaboliteLMST04030170 (LIPID MAPS)
ST 27:2;(24)O4MetaboliteLMST04030171 (LIPID MAPS)
ST 27:2;(25)O3MetaboliteLMST04030107 (LIPID MAPS)
ST 27:2;(25)O4MetaboliteLMST04030105 (LIPID MAPS)
ST 27:2;(26)O3MetaboliteLMST04030157 (LIPID MAPS)
ST 27:2;(26)O4MetaboliteLMST04030158 (LIPID MAPS)
ST 27:2;O3MetaboliteLMST04030072 (LIPID MAPS)
ST 27:2;O4MetaboliteLMST04030241 (LIPID MAPS)
ST 27:3;O4MetaboliteLMST04030149 (LIPID MAPS)

Annotated Interactions

No annotated interactions

Personal tools